top of page
LEADERSHIP
NATURAL LEADERSHIP STYLE THAT LETS FREEDOM TO CHALLENGE AND MAKE INNOVATION.
EXECUTIVE MANAGEMENT
JIMMY JONGWOO KIM,
PRESIDENT & CEO
Mr. Jong Woo Kim executes multi-level activities with a natural leadership style and commitment to excellence. He has founded 4 biotech companies under his patents. His passion for medical innovations has excited since his research trainings at Biomimetic Laboratory of Harvard Medical School and Nano-Bio Modeling Lab of Georgia Institute of Technology. Holding B.S. degree in Biomedical Engineering from Georgia Institute of Technology, USA, Mr. Kim has led the international research collaborations with surgeons and professors from Harvard University and Emory University. His 8 medical patents for tissue grafts, sterilization devices, IVD devices, and surgical staplers are applied and registered in over 45 countries.
EXECUTIVE BOARD OF DIRECTORS
DR. MIN KIM,
CHAIRMAN OF THE BOARD
Dr. Min Kim adds his surgical expertise to the R&D affairs held in the company. He was trained both in South Korea and the United States as an ENT & Head and Neck Surgeon, Plastic Reconstructive Surgeon. Over 25 years of research and medical businesses, he has devoted himself to research on medical devices, and has been training doctors on new treatment methods thousands of times around the world. He has led a team of talented researchers to create innovations for the various types of implants, next-generation medical devices and medical products. Dr. Min Kim is also known for his surgical expertise in ENT & Head and Neck Surgery and Plastic Reconstructive Surgery. He has performed surgical operations for more than 20 years as a renowned surgeon known worldwide in the field of cosmetic plastic surgery. He is the keynote speaker for international conferences such as AMWC, ECS, AFAS, ICAD, JSPRS, etc.
GILBONG HWANG,
CHAIRMAN
Mr. Gil-bong Hwang completed his master's degree in business administration at Sogang University, and based on his understanding of the medical industry, he showed outstanding management capabilities through the role of CEO of Hugel Pharma, and served as vice president of Avellino Laboratory in the ophthalmology genetic diagnosis treatment sector His multi-level mangement skills were demonstrated through multi-national companies such as GSK. He is committed to building management strategies, reorganizing business structures, developing new products, and building core human resources and capital raising.
bottom of page